Notify me when Ph.D. John P. McKearn files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SPRB | SPRUCE BIOSCIENCES, INC. | Common Stock, par value $0.001 per share | 4.2% | $140,762 | 1,759,521 | John P. McKearn, Ph.D. | 07 Jan 2025 | ||
| RPHM | OnKure Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 1.6% | $333,517 | 196,198 | John P. McKearn, Ph.D. | 16 Jan 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|